|05/02/16||8-K||Current report filing||2|
|04/22/16||3||Initial statement of beneficial ownership of securities||2|
|04/22/16||8-K||Current report filing||5|
|04/05/16||8-K||Current report filing||6|
|03/25/16||4||Statement of changes in beneficial ownership of securities||2|
|03/23/16||4||Statement of changes in beneficial ownership of securities||2|
|03/22/16||SC 13G/A||Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions||14|
|03/21/16||DEF 14A||Definitive proxy statements||43|
|03/08/16||10-K||Annual report pursuant to Section 13 and 15(d)||120|
|03/07/16||8-K||Current report filing||6|
Nivalis Therapeutics is not responsible for the content on linked websites.
The document you requested is located on the Journal of Applied Physiology website. A subscription is required to view the document.